Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Rivastigmine for the treatment of dementia associated with Alzheimer's disease or Parkinson's disease
Drug guidance

Rivastigmine for the treatment of dementia associated with Alzheimer's disease or Parkinson's disease

Neurology

5 February 2018

Guidance Recommendations

Subsidy status

Back to top